Skip to main content
OpenTrials

Clinical trial condition

Liver Neoplasms

Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.

1,743 public trials 464 recruiting studies
Refine in advanced search Browse all conditions

Liver Neoplasms trial results

Completed

A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

NCT05104567

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +29 more
Locations
  • City of Hope Site Number : 8400007 Duarte, California, United States
  • AdventHealth Orlando Site Number : 8400005 Orlando, Florida, United States
  • Seattle Cancer Care Alliance Site Number : 8400009 Seattle, Washington, United States
  • Investigational Site Number : 0560002 Brussels, Belgium
View all 29 locations
View Trial Details
Completed

A Study of Atezolizumab (Tecentriq) in Combination With Bevacizumab to Investigate Safety and Efficacy in Patients With Unresectable Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy-Amethista

NCT04487067

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations
  • IRCCS Ospedale Casa Sollievo Della Sofferenza San Giovanni Rotondo, Apulia, Italy
  • Fondazione Pascale Naples, Campania, Italy
  • Azienda Osp Uni Seconda Università Degli Studi Di Napoli Naples, Campania, Italy
  • Ospedale del Mare Naples, Campania, Italy
View all 21 locations
View Trial Details
Completed

EchoTip AcuCore Post-Market Clinical Study

NCT06358001

Conditions
Adenocarcinoma, Autoimmune Diseases, Autoimmune Pancreatitis, +34 more
Locations
  • University of California, Irvine Orange, California, United States
  • Advent Health, Porter Denver, Colorado, United States
  • Shands Hospital-University of Florida Gainesville, Florida, United States
  • University of Florida Shands Hospital Gainesville, Florida, United States
View Trial Details
Completed

ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction

NCT06856590

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +19 more
Locations
  • Necmettin Erbakan University Meram Faculty of Medicine Hospital Konya, Meram, Turkey (Türkiye)
  • Bursa Uludağ University Hospital Bursa, Nilüfer, Turkey (Türkiye)
  • Karadeniz Technical University Hospital Trabzon, Ortahisar, Turkey (Türkiye)
  • Sakarya University Hospital Sakarya, Serdivan, Turkey (Türkiye)
View all 13 locations
View Trial Details

Related conditions